Latest papers

Long-term overall survival and metastasis-free survival for men with prostate-specific antigen-recurrent prostate cancer after prostatectomy: analysis of the Center for Prostate Disease Research National Database.

No advantage of a rotational continuation phase in acute lymphoblastic leukemia in childhood treated with a BFM back-bone therapy.

Ethanol injection is highly effective for hepatocellular carcinoma smaller than 2 cm.

[Clinicopathological study of retroperitoneal sarcoma].

Prevalence and effectiveness of first-, second-, and third-line systemic therapy in a cohort of unselected patients with advanced non-small cell lung cancer.

Extracorporeal membrane oxygenation support for resection of locally advanced thoracic tumors.

Intensity-modulated radiotherapy (IMRT)/Tomotherapy following neoadjuvant chemotherapy in stage IIB-IVA/B undifferentiated nasopharyngeal carcinomas (UCNT): a mono-institutional experience.

Impact of laterality on early and late survival after pneumonectomy.

Long-term survival of VATS versus open lobectomy. FAU - Takagi, Hisato AU - Takagi H FAU - Matsui, Masafumi AU - Matsui M FAU - Umemoto, Takuya AU - Umemoto T LA - eng PT - Comment PT - Comparative Study PT - Letter PL - Netherlands TA - Ann Thorac Surg JT - The Annals of thoracic surgery JID - 15030100R SB - AIM SB - IM CON - Ann Thorac Surg. 2010 Jun;89(6):S2107-11. PMID: 20493991 MHDA- 2011/09/10 06:00 PHST- 2010/10/13 [received] PHST- 2010/11/19 [revised] PHST- 2011/01/26 [accepted] AID - S0003-4975(11)00279-7 [pii] AID - 10.1016/j.athoracsur.2011.01.089 [doi] PST - ppublish SO - Ann Thorac Surg. 2011 Jul;92(1):408-9; author reply 409-10.

Amrubicin monotherapy for patients with previously treated advanced large-cell neuroendocrine carcinoma of the lung.

Primary cT2 bladder cancer: a good candidate for radiotherapy combined with cisplatin for bladder preservation.

Intraoperative radiotherapy during a second breast-conserving procedure for relapsed breast cancer after previous external beam radiotherapy. FAU - Kraus-Tiefenbacher, Uta AU - Kraus-Tiefenbacher U FAU - Blank, Elena AU - Blank E FAU - Wenz, Frederik AU - Wenz F LA - eng PT - Comment PT - Letter PL - United States TA - Int J Radiat Oncol Biol Phys JT - International journal of radiation oncology, biology, physics JID - 7603616 SB - IM CON - Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):804-10. PMID: 20106605 MHDA- 2011/08/19 06:00 PHST- 2010/12/06 [received] PHST- 2011/02/15 [accepted] AID - S0360-3016(11)00358-0 [pii] AID - 10.1016/j.ijrobp.2011.02.038 [doi] PST - ppublish SO - Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1279-80.

In reply to Dr. King (Adjuvant radiotherapy after prostatectomy: does waiting for a detectable prostate-specific antigen level make sense?). FAU - Ohri, Nitin AU - Ohri N FAU - Dicker, Adam P AU - Dicker AP FAU - Showalter, Timothy N AU - Showalter TN LA - eng PT - Comment PT - Letter PL - United States TA - Int J Radiat Oncol Biol Phys JT - International journal of radiation oncology, biology, physics JID - 7603616 RN - EC 3.4.21.77 (Prostate-Specific Antigen) SB - IM CON - Int J Radiat Oncol Biol Phys. 2011 May 1;80(1):1-3. PMID: 21277112 MHDA- 2011/08/19 06:00 PHST- 2011/02/15 [received] PHST- 2011/02/15 [accepted] AID - S0360-3016(11)00333-6 [pii] AID - 10.1016/j.ijrobp.2011.02.032 [doi] PST - ppublish SO - Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):1279.

Locally advanced rectal cancer: a comparison of management strategies. LID - 10.2165/11591330-000000000-00000 [doi]

Vascular endothelial growth factor-targeted therapy for the treatment of renal cell carcinoma. LID - 10.2165/11591410-000000000-00000 [doi]

Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy. LID - 10.1002/cncr.25750 [doi]

Is the number of blood products transfused associated with lower survival in children with acute lymphoblastic leukemia? LID - 10.1002/pbc.22957 [doi]

Asymmetric dimethylarginine and clinical outcomes in chronic kidney disease.

[Effect of KRAS mutation status on the efficiency of Avastin therapy of colorectal cancer].

Predictive factors of tumor response after neoadjuvant chemoradiation for locally advanced rectal cancer.